With a focus on “helping the nation feel better one customer at a time,” Goodlife Pharmacy’s customers have voted with their feet, helping Goodlife to become the largest pharmaceutical retail business across East Africa.
In just under four years, Goodlife has grown to provide trusted pharmaceuticals to 600,000 customers from 19 convenient locations – with a total reach of 1.2 million people.
This innovative healthcare business defies the traditional notion of the pharmacy, by delivering a truly customer-centric brand that combines pharmacy services with wellness, beauty and diagnostics. Goodlife prides itself on being the first in the market to introduce consultation centers into all its locations and will shortly be offering telemedicine.
Crucially, pharmacy is often the first point of care for Kenyans – and Goodlife is dedicated to increasing access to healthcare through its stores, thereby improving the quality of life and wellness of East Africa’s growing consumer class. The pharmacies can be found in shopping malls and gas station locations throughout Kenya, placing health services at the heart of communities and making them accessible to all income groups.
Goodlife was recently endorsed by The Pharmaceuticals Society of Kenya as best pharmacy practice in the country; a testament to Goodlife’s ongoing commitment to excellence in pharmacy practice. It is both widely recognized and trusted as a brand that delivers quality medication, in a market where substandard and counterfeit medication are yet to be rooted out.
In 2018, an independent team within IFC recognised Goodlife as having an inclusive business model as it directly reaches people at the base of the pyramid. This is something only 10-20% of IFC investments achieve.
Goodlife plans to expand to over 100 stores by 2021, reaching over 5.5 million consumers, and creating over 700 jobs, of which approximately 400 will be held by pharmaceutical professionals.
It is tapping a high-growth market, with Kenya’s pharmacy sector already worth $725m and set to rise to $1.3bn by 2020.
LeapFrog invested in Goodlife in 2016, marking it the largest direct investment in the East African pharmacy sector to-date.
“Goodlife, with its consumer focused business model, rapid growth, and excellent management team, has proven to be a fine example of how businesses that serve a real social need can be scalable and provide good financial returns,” says Dr. Felix Olale, LeapFrog Partner and Global Co-Leader for Health Investments.
The LeapFrog team brings to bear significant health industry knowledge, operational skills and international networks, and will enable Goodlife Pharmacy to accelerate its growth across East Africa, delivering best-in-class customer care to millions of consumers across East Africa.
“Goodlife has an ambitious vision for the future of East African healthcare, centred on ensuring that millions of consumers have access to high quality, innovative healthcare that is tailored to their needs and lifestyles. This model, supported by the backing and insight of world-leading investors like LeapFrog and the IFC, is delivering substantial growth and transforming the health of East Africa in the process.”
Amaan Khalfan, CEO, Goodlife Pharmacy